Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04248517 · ClinicalTrials.gov registry record · NA

Using mHealth to Optimize Pharmacotherapy Regimens

A NA study, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT04248517 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04248517, a NA study, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

This project will use a smartphone technology to improve medication prescribing for individuals with FEP. We will collect real-time symptom and functioning data via smartphones to provide prescribers and other clinical team members with clinically relevant and time-sensitive information that will inform and promote shared decision making (SDM) and personalized interventions. The result will be a time-sensitive, data-driven, collaborative process to optimize medication regimens in order to maximize benefits, minimize harms, and promote adherence.

Interventions

  • OTHER mHealth Intervention

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2020-10-09
Est. Completion 2023-01-20
Phase NA

What the Registry Record Tells You About NCT04248517

The ClinicalTrials.gov registry entry for NCT04248517 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which mHealth Intervention is the first listed.

NCT04248517 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04248517 about?

NCT04248517 is a clinical study titled "Using mHealth to Optimize Pharmacotherapy Regimens". This project will use a smartphone technology to improve medication prescribing for individuals with FEP. We will collect real-time symptom and functioning data via smartphones to provide prescribers and other clinical team members with clinically relevant and time-sensitive information that will in...

What is the current status of trial NCT04248517?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2020-10-09. Estimated completion is 2023-01-20.

What interventions are being tested in trial NCT04248517?

The interventions under investigation include: mHealth Intervention (OTHER).

Who is sponsoring clinical trial NCT04248517?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.